Does PARATHYROID HORMONE Cause Product packaging quantity issue? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Product packaging quantity issue have been filed in association with PARATHYROID HORMONE (NATPARA (parathyroid hormone)). This represents 0.2% of all adverse event reports for PARATHYROID HORMONE.
9
Reports of Product packaging quantity issue with PARATHYROID HORMONE
0.2%
of all PARATHYROID HORMONE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product packaging quantity issue From PARATHYROID HORMONE?
Of the 9 reports, 3 (33.3%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PARATHYROID HORMONE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does PARATHYROID HORMONE Cause?
Recalled product (900)
Hypocalcaemia (784)
Blood calcium decreased (703)
Paraesthesia (364)
Muscle spasms (357)
Headache (257)
Drug ineffective (217)
Blood calcium increased (212)
Nausea (201)
Inappropriate schedule of product administration (195)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which PARATHYROID HORMONE Alternatives Have Lower Product packaging quantity issue Risk?
PARATHYROID HORMONE vs PARECOXIB
PARATHYROID HORMONE vs PARICALCITOL
PARATHYROID HORMONE vs PARITAPREVIR
PARATHYROID HORMONE vs PAROXETINE
PARATHYROID HORMONE vs PAROXETINE\PAROXETINE